Business Daily from THE HINDU group of publications
Friday, July 3, 2009
ePaper | Mobile/PDA Version | Audio | Blogs
News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Subscription

Group Sites

Update at 1700 hrs (IST)


Corporate
Orchid Chemicals gets US FDA nod for BP tablets

MUMBAI: Orchid Chemicals & Pharmaceuticals on Thursday said it has received approval from the US drug regulator for its anti-hypertensive tablets.

The company has received approval from the US Food and Drug Administration (FDA) for its anti-hypertensive tablets Amlodipine Besylate, the Chennai-based pharmaceuticals firm said in a filing to the Bombay Stock Exchange.

The approval has come for 2.5 mg, 5 mg and 10 mg tablets, the company said. With this nod, "Orchid's cumulative Abbreviated New Drug Application (ANDA) approval count stands at 32 and the total ANDA filing count stands at 50,'' the company added. - PT I

Prev: RNRL moves SC seeking modification of HC ruling
Next: Seven US banks fail in a single day

Business Line | NUS Index |

Related Topics
Alliances & Joint Ventures
Announcements
Auditing
Awards & Honours
Bonus Announcements
Company Law
Corporate Bonds
Corporate Disputes
Corporate Governance
Courts/Legal Issues
Diversification
Environment
Human Resources
Interview
IPOs
IPR
Management
Mergers & Acquisitions
New Projects
Open Offers
Outlook
Outsourcing
Overseas Borrowings
Overseas Investments
People
Performance
Preferential Allotments
Private Placement
Regulatory Bodies & Rulings
Research & Development
Restructuring
Rights Issue
Sick Units
Society & Development
Standards & Benchmarks
Taxation
Trade & Labour Unions
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright copy; 2009, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line